The side effects of bone-building bisphosphonate drugs, which include jaw bone death and femur fractures, have resulted in thousands of Fosamax lawsuits against manufacturer Merck & Co. But not all Fosamax side effects are harmful. Research has shown that bisphosphonates may increase the life span of artificial joints and even help prevent breast cancer. And now, there is reason to believe that drugs like Fosamax have a protective effect against a certain type of uterine cancer.
Results Show Bisphosphonates Reduce Cancer Rate by Nearly Half
An ongoing study at Henry Ford Hospital in Detroit finds that women who have taken bisphosphonates are roughly half as likely to develop endometrial cancer, a form of uterine cancer, than women who have never taken the drugs. Currently in its fifth year, the analysis includes 29,254 women who were between the ages of 55 and 70 at the time they were asked to participate in the trial.
Sharon Hensley Alford, the lead author of the study and a researcher at Henry Ford Hospital said that, “The results of the study suggest that use of low bone density medications may have a protective effect on endometrial cancer, or that women who take them get a less-aggressive cancer.”
While the results are promising, Alford pointed out that they are not definitive. “This was a retrospective study, with self-reported data. A clinical trial, with closely monitored data, needs to be done,” she said.
Harmful Fosamax Side Effects Lead To Thousands of Lawsuits
While the news about Fosamax and uterine cancer is a positive development, other side effects of the drug are less encouraging. One such side effect, osteonecrosis of the jaw (ONJ), is a debilitating condition that causes a loss of blood to the jaw and in some cases, death of the jawbone. Another Fosamax side effect is atypical femur fractures, so-called because they can occur with little or no trauma.
ONJ and Fosamax femur fractures have resulted in thousands of lawsuits in state and federal courts in New York and New Jersey. They are contained in the following mass tort cases:
- In Re: Fosamax Products Liability Litigation (New York federal court; 973 ONJ cases)
- In Re: Fosamax (Alendronate Sodium) Products Liability Litigation (No. II) (New Jersey federal court; 373 femur fracture cases)
- In Re: Fosamax Litigation (New Jersey Superior Court; 1,571 ONJ and femur fracture cases)
Contact RLG to Discuss a Fosamax Lawsuit
If you suffered a femur fracture that you believe was caused by Fosamax, you might be entitled to compensation from Merck. To find out whether you qualify for a lawsuit, submit the details of your case to the Rottenstein Law Group. Our lawyers, with more than 25 collective years of experience representing injured consumers, have the know-how to take on a large corporation like Merck. Contact RLG now by filling out this form or calling 1-877-332-2347.
To Learn More, Have a Look at RLG’s Fosamax Infographic